Skip to main content
NIH funding notice RFA-MH-18-702

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)

Closed on February 18, 2021.

Posted
November 14, 2017
Close date
February 18, 2021
Activity codes
R61, R33
Institutes taking part
NIMH

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: RFA-MH-17-600 Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)

Replaced by PAR-21-137.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,767,982 in first-year total cost, median $946,653.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-D (02)]3
  2. Special Emphasis Panel[ZMH1 ERB-D (04)]2
  3. Special Emphasis Panel[ZMH1 ERB-N (02)]2
  4. Special Emphasis Panel[ZMH1 ERB-D (03)]1
  5. Special Emphasis Panel[ZMH1 ERB-D (06)]1

Most frequent institutions

  1. CENTRE FOR ADDICTION AND MENTAL HEALTH1
  2. EMORY UNIVERSITY1
  3. MCLEAN HOSPITAL1
  4. NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1
  5. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
Competing awards under RFA-MH-18-702 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Individually targeted neuromodulation for contamination-based OCD1R61MH121640-01A1BRENNAN, BRIAN P.MCLEAN HOSPITAL, MA$1,069,368ZMH1
2021Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depression1R61MH125126-01ABBOTT, CHRISTOPHER CUNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM$756,111ZMH1
2020Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression1R61MH121625-01A1FELGER, JENNIFER CEMORY UNIVERSITY, GA$1,406,314ZMH1
2020Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics1R61MH123754-01CONELEA, CHRISTINE AUNIVERSITY OF MINNESOTA, MN$1,248,895ZMH1
2020Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum Disorders1R61MH120188-01A1BLUMBERGER, DANIEL M.VOINESKOS, ARISTOTLE NICHOLASCENTRE FOR ADDICTION AND MENTAL HEALTH, ON$1,026,903ZMH1
2020Nicotinic Modulation of the Cognitive Control System in Late-Life Depression1R61MH122464-01TAYLOR, WARREN DVANDERBILT UNIVERSITY MEDICAL CENTER, TN$946,653ZMH1
2020Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression (TRIADE)1R61MH122647-01CASSANO, PAOLOIOSIFESCU, DAN VLADNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$863,648ZMH1
2019Morning Light Treatment for Traumatic Stress: the Role of Amygdala Reactivity1R61MH117157-01A1BURGESS, HELEN JULIAZALTA, ALYSON KAYUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$803,761ZMH1
2019D-serine augmentation of neuroplasticity-based auditory learning in schizophrenia1R61MH116093-01A1KANTROWITZ, JOSHUA TOLKIENNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY$646,329ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-18-702: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required) | ScienceDex | ConductScience